Does caffeine change the effect of sleep deprivation on moderate to severe depressed patients? 2009

Alexandre W Schwartzhaupt, and Diogo R Lara, and Vânia N Hirakata, and Alice Schuch, and Ellen Almeida, and Leonardo Silveira, and Marco A K Caldieraro, and Marcelo P Fleck
Post-Graduate Program in Psychiatry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.

BACKGROUND Sleep deprivation (SD) has been used as an alternative approach to treat major depressive disorder (MDD). Caffeine, due to its stimulating effect, could be an alternative to promote sleep deprivation. However, there are no data about its potential influence on the antidepressive effect of SD. The objective of this study is to assess the effect of caffeine on SD in non-psychotic patients with moderate to severe unipolar depression. METHODS Randomized, double-blind, crossover clinical trial comparing caffeine and placebo in moderate to severe depressed patients who underwent total sleep deprivation (SD). The patients were assessed with items of the Bond-Lader scale, the 6-item Hamilton Depression Rating Scale (HAMD-6), and the Clinical Global Impression (CGI)-Severity/Improvement. RESULTS Twenty patients participated in this study. The patients who consumed caffeine presented the same level of energy before and after sleep deprivation (lethargic-energetic item of the Bond-Lader scale), while the patients in the placebo group had a reduced level of energy after sleep deprivation (p=0.0045). There was no difference between the caffeine and placebo groups in the other items of the Bond-Lader scale. CONCLUSIONS The combined use of caffeine and SD can be a useful strategy to keep the patient awake without impairing the effect of SD on depressed outpatients. However, further studies involving patients who have responded to SD are needed in order to verify if caffeine also does not interfere with the results in this group.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D003865 Depressive Disorder, Major Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5) Depression, Involutional,Major Depressive Disorder,Melancholia, Involutional,Paraphrenia, Involutional,Psychosis, Involutional,Depressive Disorders, Major,Involutional Depression,Involutional Melancholia,Involutional Paraphrenia,Involutional Paraphrenias,Involutional Psychoses,Involutional Psychosis,Major Depressive Disorders,Paraphrenias, Involutional,Psychoses, Involutional
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females

Related Publications

Alexandre W Schwartzhaupt, and Diogo R Lara, and Vânia N Hirakata, and Alice Schuch, and Ellen Almeida, and Leonardo Silveira, and Marco A K Caldieraro, and Marcelo P Fleck
February 1976, Acta psychiatrica Scandinavica,
Alexandre W Schwartzhaupt, and Diogo R Lara, and Vânia N Hirakata, and Alice Schuch, and Ellen Almeida, and Leonardo Silveira, and Marco A K Caldieraro, and Marcelo P Fleck
January 2022, Frontiers in behavioral neuroscience,
Alexandre W Schwartzhaupt, and Diogo R Lara, and Vânia N Hirakata, and Alice Schuch, and Ellen Almeida, and Leonardo Silveira, and Marco A K Caldieraro, and Marcelo P Fleck
December 2015, Sleep & breathing = Schlaf & Atmung,
Alexandre W Schwartzhaupt, and Diogo R Lara, and Vânia N Hirakata, and Alice Schuch, and Ellen Almeida, and Leonardo Silveira, and Marco A K Caldieraro, and Marcelo P Fleck
April 1992, The American journal of psychiatry,
Alexandre W Schwartzhaupt, and Diogo R Lara, and Vânia N Hirakata, and Alice Schuch, and Ellen Almeida, and Leonardo Silveira, and Marco A K Caldieraro, and Marcelo P Fleck
August 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Alexandre W Schwartzhaupt, and Diogo R Lara, and Vânia N Hirakata, and Alice Schuch, and Ellen Almeida, and Leonardo Silveira, and Marco A K Caldieraro, and Marcelo P Fleck
July 1976, Journal of the American Geriatrics Society,
Alexandre W Schwartzhaupt, and Diogo R Lara, and Vânia N Hirakata, and Alice Schuch, and Ellen Almeida, and Leonardo Silveira, and Marco A K Caldieraro, and Marcelo P Fleck
March 1995, International journal of clinical pharmacology and therapeutics,
Alexandre W Schwartzhaupt, and Diogo R Lara, and Vânia N Hirakata, and Alice Schuch, and Ellen Almeida, and Leonardo Silveira, and Marco A K Caldieraro, and Marcelo P Fleck
December 1981, Psychiatry research,
Alexandre W Schwartzhaupt, and Diogo R Lara, and Vânia N Hirakata, and Alice Schuch, and Ellen Almeida, and Leonardo Silveira, and Marco A K Caldieraro, and Marcelo P Fleck
August 1976, The New Zealand nursing journal. Kai tiaki,
Alexandre W Schwartzhaupt, and Diogo R Lara, and Vânia N Hirakata, and Alice Schuch, and Ellen Almeida, and Leonardo Silveira, and Marco A K Caldieraro, and Marcelo P Fleck
June 1987, Psychiatry research,
Copied contents to your clipboard!